28-Mar-2024
No headlines found.
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
Globe Newswire (Fri, 8-Mar 8:00 AM ET)
Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
Globe Newswire (Wed, 28-Feb 8:00 AM ET)
Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Globe Newswire (Tue, 6-Feb 8:00 AM ET)
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.
Ovid Therapeutics trades on the NASDAQ stock market under the symbol OVID.
As of March 28, 2024, OVID stock price was flat at $3.05 with 137,184 million shares trading.
OVID has a beta of 0.77, meaning it tends to be less sensitive to market movements. OVID has a correlation of 0.03 to the broad based SPY ETF.
OVID has a market cap of $215.58 million. This is considered a Small Cap stock.
In the last 3 years, OVID stock traded as high as $4.80 and as low as $1.41.
The top ETF exchange traded funds that OVID belongs to (by Net Assets): VTI, IWM, VXF, IWN, IBB.
OVID has underperformed the market in the last year with a return of +8.9%, while the SPY ETF gained +33.6%. In the last 3 month period, OVID fell short of the market, returning -10.3%, while SPY returned +10.1%. However, in the most recent 2 weeks OVID has outperformed the stock market by returning +8.2%, while SPY returned +1.7%.
OVID support price is $2.92 and resistance is $3.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OVID stock will trade within this expected range on the day.